Venanprubart (LY-3361237) is a humanized monoclonal antibody designed as a BTLA/CD272 agonist for research use. It is applied in preclinical studies of autoimmune diseases like psoriasis, facilitating both in vitro mechanistic studies and in vivo model validation.
Konzentration:
5 mg/mL
Molekulargewicht:
145.15 kDa
Reinheit:
99.80% (May vary between batches)
CAS Nummer:
[2635407-50-8]
Target-Kategorie:
Immunology/Inflammation related
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten